Citadel Advisors’s China Nepstar Chain Drugstore NPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-13,906
Closed -$34K – 8248
2016
Q2
$34K Sell
13,906
-17,018
-55% -$41.8K ﹤0.01% 6497
2016
Q1
$76K Buy
30,924
+18,867
+156% +$43.7K ﹤0.01% 6140
2015
Q4
$29K Sell
12,057
-5,898
-33% -$13.9K ﹤0.01% 7692
2015
Q3
$38K Buy
+17,955
New +$39.4K ﹤0.01% 7779
2013
Q3
– Sell
-6,783
Closed -$10K – 7004
2013
Q2
$10K Buy
+6,783
New +$11.6K ﹤0.01% 6246

Citadel Advisors's NPD Position: Q3 2016 in Review

Citadel Advisors sold out of China Nepstar Chain Drugstore (NPD) in Q3 2016, closing a stake of 13,906 shares — an estimated $34K sold.

Citadel Advisors first reported a position in NPD in Q2 2013 and held it in 5 quarters. The position peaked at $76K in Q1 2016. 0 funds tracked by Wall St. Rank hold NPD as of Q3 2016.

  • Citadel Advisors reported no remaining China Nepstar Chain Drugstore position as of Q3 2016 after selling out during the quarter.
  • Citadel Advisors sold 13,906 China Nepstar Chain Drugstore shares in Q3 2016, an estimated $34K.
  • Citadel Advisors first reported a position in China Nepstar Chain Drugstore in Q2 2013 and held it in 5 quarters.
  • Citadel Advisors's China Nepstar Chain Drugstore position peaked at $76K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held China Nepstar Chain Drugstore as of Q3 2016.

Based on Citadel Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.